Oman wound gel market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

Oman Wound Gel Market, valued at USD 13 million, grows due to rising chronic wounds, aging population, and advanced care tech, led by Muscat and Dhofar regions.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAC9503

Pages:91

Published On:November 2025

About the Report

Base Year 2024

Oman Wound Gel Market Overview

  • The Oman Wound Gel Market is valued at USD 13 million, based on a five-year historical analysis and regional share estimates. This growth is primarily driven by the increasing prevalence of chronic wounds, rising healthcare expenditure, and advancements in wound care technologies. The demand for effective wound management solutions has surged, particularly in the context of an aging population and the growing incidence of diabetes and obesity-related complications. Digital transformation and the expansion of e-commerce platforms have further improved product accessibility, supporting market growth.
  • Muscat and Dhofar are the dominant regions in the Oman Wound Gel Market due to their well-established healthcare infrastructure and higher concentration of hospitals and clinics. The urbanization in these areas has led to increased healthcare access, driving the demand for advanced wound care products. Additionally, the presence of key healthcare facilities and professionals in these cities contributes to their market dominance.
  • In 2023, the Omani government implemented the "Medical Devices and Products Registration Regulation, 2023" issued by the Ministry of Health. This regulation mandates that all wound gel products must undergo rigorous clinical testing and obtain formal approval from the Ministry of Health prior to market entry. The regulation covers product safety, efficacy, labeling, and post-market surveillance, ensuring only safe and effective products are available to consumers and improving patient outcomes.
Oman Wound Gel Market Size

Oman Wound Gel Market Segmentation

By Type:The market is segmented into various types of wound gels, including Hydrogel Wound Gel, Alginate Wound Gel, Antimicrobial Wound Gel (Silver, Non-silver), Collagen Wound Gel, Honey-based Wound Gel, Silicone-based Wound Gel, and Others (e.g., Polymeric, Combination Gels). Hydrogel Wound Gel remains the leading sub-segment due to its superior moisture-retentive properties, which are ideal for managing both chronic and acute wounds. The increasing awareness of advanced wound care solutions and the growing preference for non-invasive treatment options are driving demand for hydrogel products. Product innovation and ongoing research in hydrogel formulations further support segment growth.

Oman Wound Gel Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Home Healthcare, Long-term Care Facilities, Outpatient Clinics, Specialty Clinics, Ambulatory Surgery Centers, and Others. Hospitals are the dominant end-user segment, primarily due to the high volume of wound care procedures performed in these settings. The increasing number of surgical procedures and the rising incidence of chronic wounds in hospital settings are driving the demand for advanced wound care products. Institutional healthcare settings continue to account for the largest revenue share, reflecting the central role of hospitals in wound management.

Oman Wound Gel Market segmentation by End-User.

Oman Wound Gel Market Competitive Landscape

The Oman Wound Gel Market is characterized by a dynamic mix of regional and international players. Leading participants such as Smith & Nephew, Mölnlycke Health Care, 3M Health Care (now Solventum), ConvaTec, Coloplast, Medline Industries, Acelity (now part of 3M/Solventum), Derma Sciences (Integra LifeSciences), Hartmann Group, B. Braun Melsungen AG, Ethicon (Johnson & Johnson), Advanced Medical Solutions Group, Integra LifeSciences, Medtronic, Systagenix (Acelity/3M/Solventum) contribute to innovation, geographic expansion, and service delivery in this space.

Smith & Nephew

1856

London, UK

Mölnlycke Health Care

1849

Gothenburg, Sweden

3M Health Care

1902

St. Paul, Minnesota, USA

ConvaTec

1978

Reading, UK

Coloplast

1957

Humlebæk, Denmark

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (Oman/Middle East wound gel segment)

Market Penetration Rate (Share of Oman wound gel market)

Product Portfolio Breadth (Number of wound gel SKUs/variants)

Regulatory Approvals (MOH Oman, CE, FDA, etc.)

Distribution Network Coverage (Hospitals, Pharmacies, E-commerce)

Oman Wound Gel Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Wounds:The prevalence of chronic wounds in Oman is rising, with an estimated 1.5 million people affected by diabetes, leading to a significant increase in diabetic ulcers. According to the World Health Organization, the number of diabetic patients is projected to reach 2.2 million by future. This growing patient population necessitates advanced wound care solutions, driving demand for specialized products like wound gels, which are essential for effective management and healing.
  • Rising Awareness about Advanced Wound Care Products:Awareness of advanced wound care products is increasing among healthcare professionals and patients in Oman. Educational initiatives and training programs have led to a 25% rise in the adoption of modern wound care techniques over the past three years. This shift is supported by the Ministry of Health's efforts to improve healthcare standards, resulting in a greater emphasis on using innovative products that enhance healing outcomes and reduce complications.
  • Growth in Healthcare Infrastructure:Oman is investing heavily in healthcare infrastructure, with a budget allocation of OMR 1.1 billion for health services in future. This investment is expected to enhance the availability of advanced medical facilities and wound care services. The establishment of new hospitals and clinics, particularly in rural areas, is projected to increase access to wound care products, thereby driving market growth and improving patient outcomes across the country.

Market Challenges

  • High Cost of Advanced Wound Care Products:The high cost of advanced wound care products poses a significant challenge in Oman, where healthcare budgets are constrained. For instance, advanced wound gels can cost up to OMR 45 per unit, making them less accessible for patients and healthcare providers. This financial barrier limits the widespread adoption of these products, particularly in lower-income segments, hindering overall market growth and patient care quality.
  • Limited Availability of Skilled Healthcare Professionals:The shortage of skilled healthcare professionals in Oman is a critical challenge for the wound care market. Currently, there are 2.2 doctors per 1,000 people, which is below the global average of 3.5. This shortage affects the quality of wound care services and the effective use of advanced products, as healthcare providers may lack the necessary training to implement modern wound management techniques, ultimately impacting patient outcomes.

Oman Wound Gel Market Future Outlook

The future of the Oman wound gel market appears promising, driven by ongoing advancements in healthcare technology and increasing investments in medical research. As the healthcare sector continues to evolve, the integration of digital health solutions and telemedicine is expected to enhance patient monitoring and care. Furthermore, the growing emphasis on personalized medicine will likely lead to the development of tailored wound care products, improving healing rates and patient satisfaction in the coming years.

Market Opportunities

  • Expansion of E-commerce Platforms for Wound Care Products:The rise of e-commerce in Oman presents a significant opportunity for wound care product distribution. With online sales projected to grow by 20% annually, companies can reach a broader audience, including remote areas. This accessibility can enhance patient access to advanced wound care solutions, driving market growth and improving overall healthcare outcomes.
  • Increasing Investment in Healthcare R&D:The Omani government is increasing its investment in healthcare research and development, with a projected budget of OMR 250 million for future. This funding will support innovation in wound care technologies, fostering collaborations between universities and healthcare providers. Such partnerships can lead to the development of new products and solutions, addressing unmet needs in the wound care market and enhancing patient care.

Scope of the Report

SegmentSub-Segments
By Type

Hydrogel Wound Gel

Alginate Wound Gel

Antimicrobial Wound Gel (Silver, Non-silver)

Collagen Wound Gel

Honey-based Wound Gel

Silicone-based Wound Gel

Others (e.g., Polymeric, Combination Gels)

By End-User

Hospitals

Home Healthcare

Long-term Care Facilities

Outpatient Clinics

Specialty Clinics

Ambulatory Surgery Centers

Others

By Application

Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers)

Acute Wounds (Surgical Incisions, Traumatic Wounds, Burns, Lacerations, Abrasions)

Others

By Distribution Channel

Direct Sales

Online Retail/E-commerce

Pharmacies

Hospital Pharmacies

Others

By Region

Muscat

Dhofar

Al Batinah

Al Dakhiliyah

Others

By Product Formulation

Natural Formulations

Synthetic Formulations

Combination Formulations

Others

By Packaging Type

Single-use Packaging

Multi-use Packaging

Bulk Packaging

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Oman Medical Specialty Board)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers (e.g., Hospitals, Clinics)

Pharmaceutical Companies

Medical Device Suppliers

Insurance Companies

Players Mentioned in the Report:

Smith & Nephew

Molnlycke Health Care

3M Health Care (now Solventum)

ConvaTec

Coloplast

Medline Industries

Acelity (now part of 3M/Solventum)

Derma Sciences (Integra LifeSciences)

Hartmann Group

B. Braun Melsungen AG

Ethicon (Johnson & Johnson)

Advanced Medical Solutions Group

Integra LifeSciences

Medtronic

Systagenix (Acelity/3M/Solventum)

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Oman Wound Gel Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Oman Wound Gel Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Oman Wound Gel Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic wounds
3.1.2 Rising awareness about advanced wound care products
3.1.3 Growth in the healthcare infrastructure
3.1.4 Technological advancements in wound care solutions

3.2 Market Challenges

3.2.1 High cost of advanced wound care products
3.2.2 Limited availability of skilled healthcare professionals
3.2.3 Regulatory hurdles in product approvals
3.2.4 Competition from traditional wound care products

3.3 Market Opportunities

3.3.1 Expansion of e-commerce platforms for wound care products
3.3.2 Increasing investment in healthcare R&D
3.3.3 Collaborations with healthcare providers
3.3.4 Growing demand for personalized wound care solutions

3.4 Market Trends

3.4.1 Shift towards bioactive wound dressings
3.4.2 Integration of digital health technologies
3.4.3 Focus on sustainability in product development
3.4.4 Rise in home healthcare services

3.5 Government Regulation

3.5.1 Stricter quality control measures for wound care products
3.5.2 Guidelines for the use of antimicrobial agents
3.5.3 Regulations on labeling and marketing of wound care products
3.5.4 Compliance requirements for clinical trials

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Oman Wound Gel Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Oman Wound Gel Market Segmentation

8.1 By Type

8.1.1 Hydrogel Wound Gel
8.1.2 Alginate Wound Gel
8.1.3 Antimicrobial Wound Gel (Silver, Non-silver)
8.1.4 Collagen Wound Gel
8.1.5 Honey-based Wound Gel
8.1.6 Silicone-based Wound Gel
8.1.7 Others (e.g., Polymeric, Combination Gels)

8.2 By End-User

8.2.1 Hospitals
8.2.2 Home Healthcare
8.2.3 Long-term Care Facilities
8.2.4 Outpatient Clinics
8.2.5 Specialty Clinics
8.2.6 Ambulatory Surgery Centers
8.2.7 Others

8.3 By Application

8.3.1 Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers)
8.3.2 Acute Wounds (Surgical Incisions, Traumatic Wounds, Burns, Lacerations, Abrasions)
8.3.3 Others

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Online Retail/E-commerce
8.4.3 Pharmacies
8.4.4 Hospital Pharmacies
8.4.5 Others

8.5 By Region

8.5.1 Muscat
8.5.2 Dhofar
8.5.3 Al Batinah
8.5.4 Al Dakhiliyah
8.5.5 Others

8.6 By Product Formulation

8.6.1 Natural Formulations
8.6.2 Synthetic Formulations
8.6.3 Combination Formulations
8.6.4 Others

8.7 By Packaging Type

8.7.1 Single-use Packaging
8.7.2 Multi-use Packaging
8.7.3 Bulk Packaging
8.7.4 Others

9. Oman Wound Gel Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (Oman/Middle East wound gel segment)
9.2.4 Market Penetration Rate (Share of Oman wound gel market)
9.2.5 Product Portfolio Breadth (Number of wound gel SKUs/variants)
9.2.6 Regulatory Approvals (MOH Oman, CE, FDA, etc.)
9.2.7 Distribution Network Coverage (Hospitals, Pharmacies, E-commerce)
9.2.8 Pricing Competitiveness (Average selling price vs. market average)
9.2.9 Brand Recognition (Healthcare professional and patient awareness in Oman)
9.2.10 Customer Satisfaction Score (Oman end-user feedback)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Smith & Nephew
9.5.2 Mölnlycke Health Care
9.5.3 3M Health Care (now Solventum)
9.5.4 ConvaTec
9.5.5 Coloplast
9.5.6 Medline Industries
9.5.7 Acelity (now part of 3M/Solventum)
9.5.8 Derma Sciences (Integra LifeSciences)
9.5.9 Hartmann Group
9.5.10 B. Braun Melsungen AG
9.5.11 Ethicon (Johnson & Johnson)
9.5.12 Advanced Medical Solutions Group
9.5.13 Integra LifeSciences
9.5.14 Medtronic
9.5.15 Systagenix (Acelity/3M/Solventum)

10. Oman Wound Gel Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Defense
10.1.3 Ministry of Education
10.1.4 Ministry of Social Development

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Infrastructure Investments
10.2.2 Energy Efficiency Initiatives

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Home Care Providers
10.3.3 Long-term Care Facilities

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Acceptance

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Cost Savings Analysis
10.5.2 Performance Metrics

11. Oman Wound Gel Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging Considerations

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership Considerations

12.2 Partnerships Evaluation


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from health authorities and medical associations in Oman
  • Review of published articles and journals on wound care and gel formulations
  • Examination of trade statistics and import/export data related to wound care products

Primary Research

  • Interviews with healthcare professionals, including surgeons and dermatologists
  • Surveys conducted with hospital procurement managers and pharmacy directors
  • Focus groups with patients and caregivers to understand product preferences

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and focus group feedback
  • Triangulation of data from healthcare providers, manufacturers, and regulatory bodies
  • Sanity checks through comparison with historical market trends and growth rates

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare expenditure in Oman as a basis for market potential
  • Segmentation of the market by product type, including hydrogel, alginate, and foam gels
  • Incorporation of demographic data to assess the prevalence of wounds and injuries

Bottom-up Modeling

  • Collection of sales data from leading wound gel manufacturers operating in Oman
  • Estimation of average selling prices based on product type and distribution channel
  • Volume estimates derived from hospital usage rates and outpatient treatment statistics

Forecasting & Scenario Analysis

  • Multi-variable forecasting using factors such as population growth and healthcare access
  • Scenario analysis based on potential regulatory changes and market entry of new products
  • Development of baseline, optimistic, and pessimistic market growth scenarios through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Procurement Departments60Procurement Managers, Supply Chain Coordinators
Pharmacy Retail Sector50Pharmacy Owners, Pharmacists
Healthcare Professionals80Surgeons, Dermatologists, General Practitioners
Patient Focus Groups40Patients with chronic wounds, Caregivers
Manufacturers and Distributors40Product Managers, Sales Representatives

Frequently Asked Questions

What is the current value of the Oman Wound Gel Market?

The Oman Wound Gel Market is valued at approximately USD 13 million, driven by factors such as the increasing prevalence of chronic wounds, rising healthcare expenditure, and advancements in wound care technologies.

Which regions dominate the Oman Wound Gel Market?

What regulatory changes have impacted the Oman Wound Gel Market?

What types of wound gels are available in Oman?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022